Durvalumab Lung Cancer Survival Rate Latest Research
Did you know that durvalumab can significantly help patients with stage III lung cancer? Recent studies show these patients have […]
Latest cancer research
Treating Stage 4 Lung Cancer: Latest Treatment Options
Did you know only 8 percent of people with stage 4 non-small cell lung cancer (NSCLC) survive five years? This
Immunotherapy Success Rate for Lung Cancer: Latest Data
Did you know that the survival rate for all types of non-small cell lung cancer (NSCLC) has gone up greatly?